Skip to Content

Neonatal Education Symposium

Conference: October 4, 2024
Controversies in standards of care: treatment advances for the high-risk neonate.

Neonatal Education Symposium Agenda

Coming soon!

Conference Objectives

Coming soon!

Target Audience

This is a program for Neonatal Nurses, Nurse Practitioners, Neonatologists, Pediatricians, Pediatric Sub specialists, Respiratory Therapists, Dieticians and Allied Health Professionals who wish to increase their knowledge and understanding of the latest clinically applicable concepts as they relate to the high-risk neonates.


Overland Park Regional Medical Center is accredited by the Colorado Medical Society to provide continuing medical education for physicians. Overland Park Regional Medical Center designates this live activity for 3.0 CME credits for the pre-conference and 6.0 CME credits for the main conference.

Overland Park Regional Medical Center is approved as a provider of continuing education in nursing by the Kansas State Board of Nursing. This course offering is approved for 4.4 contact hours for the pre-conference and 7.5 contact hours for the main conference for RN, LPN or APRN relicensure. Kansas State Board of Nursing Provider No. LT0225-0738. The program must be attended in its entirety to receive continuing education credit. Any participant wishing other continuing education credit must contact his/her professional organization for approval.

Conference Speakers

Neonatal Education Symposium Speakers

Jeff Segar, M.D.

Jeff Segar, M.D. is Professor of Pediatrics and Physiology at the Medical College of Wisconsin in Milwaukee and Vice Chair for Faculty Development in the Department of Pediatrics. He is a graduate of the University of Wisconsin-Madison School of Medicine and completed his training in pediatrics and neonatal-perinatal medicine at the University of Iowa. After completing his training, he remained at Iowa over 25 years, serving as Director of the Division of Neonatology for 11 years. Throughout this time, he was actively involved in basic, translational, and clinical research, with a primary focus on developmental cardiovascular and renal physiology in the fetal and newborn sheep model. He has a sustained record of extramural funding for his work and is currently the primary investigator on two NIH R01 grants. Over the past decade, he has expanded his interests in neonatal nephrology and has published extensively on fluid and electrolyte management in the preterm infant. He relocated from Iowa to the Medical College of Wisconsin in 2019 where he has been able to undertake studies in sodium homeostasis and metabolism in a mouse model, with a focus on the cardiometabolic effects of early life sodium depletion. He is in the process of translating this work to the preterm infant.

Erika Howe, M.D.

Gaining Clarity in Your Clinical Career and Beyond

Dr. Howe is a board-certified Hospitalist and a nationally known educator, wife, and mother to three crazy kids. As a prolific speaker and lifelong advocate for improved wellness and burnout, she has given hundreds of talks both nationally and internationally on topics like conflict management and boundary setting. In 2018, she founded the Women Physicians Wellness Conference—a 3-day event hosted in Aruba, Grand Cayman, and Amelia Island exclusively for women physicians--as a way of bringing women physicians together to share their struggles and their strategies for success. Her most recent addition to WPW–the first Women Professionals Wellness Conference–is now open to all women this coming January 2025 because ultimately, Dr. Howe believes we are stronger together and hopes to inspire others to find the courage, clarity, and community to succeed on their own terms.

Jonathan Kline, M.D.

Advances in the Limits of Viability From Fetus to Neonate at 22 to 23 Weeks Gestation

Dr. Jonathan Klein completed his undergraduate education at Johns Hopkins University, attended medical school at the Medical College of Virginia, Virginia Commonwealth University, completed pediatric residency at the University of Texas Southwestern Medical Center, Children's Medical Center Dallas, and Neonatology Fellowship at New England Medical Center, Boston Floating Hospital, Tufts University. He has been a Professor of Pediatrics, at the University of Iowa, since 1990 and is currently Professor Emeritus, after serving as NICU Medical Director from 2005 to 2023. Dr. Klein and the team at University of Iowa Stead Family Children’s Hospital NICU have widely published and shared their experience on the outcomes of premature infants born at 22-23 weeks gestation with active management. He has cared for infants born at 22 weeks gestation in Iowa since 2008 and has lectured nationally and internationally on the management of periviable infants born before 24 weeks gestation since 2015. Dr. Klein has worked with multiple modes of High Frequency Ventilation since 1987 and has extensive experience and publications on the use of First Intention High Frequency Jet Ventilation for extremely premature infants.

Matthew Grossman, M.D.

Managing Neonatal Abstinence Syndrome: The Origin of Eat, Sleep, Console

Matthew Grossman, M.D. graduated from SUNY Stony Brook School of Medicine in 2003 and completed his pediatric residency at Yale-New Haven Children’s Hospital (YNHCH) in 2006. He is an Associate Professor of Pediatrics at Yale School of Medicine and a pediatric hospitalist. He has been the quality and safety officer for YNHCH since 2013 and was named the Vice-chair for Quality for the Department of Pediatrics in 2017. His team was awarded the 2015 Pediatric Quality Award from the Children’s Hospital Association for their work on improving outcomes for infants with neonatal abstinence syndrome and again in 2017 for their work on reducing serious safety events.

Kari Roberts, M.D.

Surfactant Administration through Laryngeal or Supraglottic Airways (SALSA): You can have NIV and surfactant too!

Kari Roberts, M.D. is a Professor of Pediatrics and neonatologist at the University of Minnesota. She attended medical school at the University of Minnesota and pediatric residency and fellowship at Dartmouth Hitchcock Medical Center. Her clinical interest centers on surfactant administration through laryngeal (LMA) or supraglottic airways (SALSA). She was the Principal Investigator of an animal and human trial which is the largest national, multi-center, randomized controlled trial published to date. In addition, she is active in device development and holds several patents. She is currently involved in development of an LMA for use in extremely premature infants.

Rene Amaya, M.D.


Coming soon!